Garrett Michael Frampton
Foundation Medicine (United States) · 662 works · 43,516 citations · h-index 86
Top works
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- Foxp3 occupancy and regulation of key target genes during T-cell stimulation
- Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
- Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
- Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state
- A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
- Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations
- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting